Eip Pharma Inc
Clinical trials sponsored by Eip Pharma Inc, explained in plain language.
-
Could a pill boost brain recovery after stroke? new trial begins
Disease control OngoingThis study tests whether a drug called neflamapimod can improve recovery of movement and thinking after a moderate to severe ischemic stroke. About 90 adults aged 45 and older will receive either the drug or a placebo for 12 weeks. The goal is to see if the drug helps reduce disa…
Phase: PHASE2 • Sponsor: EIP Pharma Inc • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a pill help restore speech in progressive aphasia?
Symptom relief OngoingThis study tests a drug called neflamapimod in 20 people with a language disorder called nonfluent variant primary progressive aphasia (nfvPPA). The goal is to see if the drug is safe and if it can improve language symptoms. Participants will receive either the drug or a placebo …
Phase: PHASE2 • Sponsor: EIP Pharma Inc • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC